240 related articles for article (PubMed ID: 31751164)
1. New immunotherapy in the treatment of advanced renal cancer.
Muto A; Gridelli C
Expert Opin Emerg Drugs; 2019 Dec; 24(4):233-237. PubMed ID: 31751164
[No Abstract] [Full Text] [Related]
2. Emerging immunotherapy in advanced renal cell carcinoma.
Mendiratta P; Rini BI; Ornstein MC
Urol Oncol; 2017 Dec; 35(12):687-693. PubMed ID: 28889919
[TBL] [Abstract][Full Text] [Related]
3. Emerging therapeutics in refractory renal cell carcinoma.
Koshkin VS; Rini BI
Expert Opin Pharmacother; 2016 Jun; 17(9):1225-32. PubMed ID: 27112171
[TBL] [Abstract][Full Text] [Related]
4. Emerging role for novel immunotherapy agents in metastatic renal cell carcinoma: from bench to bedside.
Weinstock M; McDermott DF
Am Soc Clin Oncol Educ Book; 2015; ():e291-7. PubMed ID: 25993188
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma.
Labriola MK; Batich KA; Zhu J; McNamara MA; Harrison MR; Armstrong AJ; George DJ; Zhang T
Clin Genitourin Cancer; 2019 Jun; 17(3):e513-e521. PubMed ID: 30858035
[TBL] [Abstract][Full Text] [Related]
6. Renal cell carcinoma: novel treatments for advanced disease.
Huland E; Heinzer H
Curr Opin Urol; 2003 Nov; 13(6):451-6. PubMed ID: 14560137
[TBL] [Abstract][Full Text] [Related]
7. Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma.
Flippot R; Escudier B; Albiges L
Drugs; 2018 Sep; 78(14):1443-1457. PubMed ID: 30187355
[TBL] [Abstract][Full Text] [Related]
8. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
9. The Past, Present and Future of Immunotherapy for Metastatic Renal Cell Carcinoma.
Chang AJ; Zhao L; Zhu Z; Boulanger K; Xiao H; Wakefield MR; Bai Q; Fang Y
Anticancer Res; 2019 Jun; 39(6):2683-2687. PubMed ID: 31177102
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of advanced renal cell carcinoma: Current and future therapies.
Gill D; Hahn AW; Sonpavde G; Agarwal N
Hum Vaccin Immunother; 2016 Dec; 12(12):2997-3004. PubMed ID: 27494417
[TBL] [Abstract][Full Text] [Related]
11. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
Thomas JS; Kabbinavar F
Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
[TBL] [Abstract][Full Text] [Related]
12. The current state of immune checkpoint inhibitors in the first-line treatment of renal cancer.
Rassy EE; Khoury Abboud RM; Ibrahim N; Assi T; Aoun F; Kattan J
Immunotherapy; 2018 Sep; 10(12):1047-1052. PubMed ID: 30185138
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in immunotherapy for kidney cancer.
Ball MW; Allaf ME; Drake CG
Discov Med; 2016 Apr; 21(116):305-13. PubMed ID: 27232516
[TBL] [Abstract][Full Text] [Related]
14. Overview of current and future systemic therapy for metastatic renal cell carcinoma.
Osawa T; Takeuchi A; Kojima T; Shinohara N; Eto M; Nishiyama H
Jpn J Clin Oncol; 2019 May; 49(5):395-403. PubMed ID: 30722031
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy.
Venur VA; Joshi M; Nepple KG; Zakharia Y
Drug Des Devel Ther; 2017; 11():1175-1182. PubMed ID: 28442891
[TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy for renal cell carcinoma - current status].
Grimm MO; Foller S
Aktuelle Urol; 2018 Apr; 49(2):187-191. PubMed ID: 29587324
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of metastatic renal cell cancer.
Fishman M; Seigne J
Cancer Control; 2002; 9(4):293-304. PubMed ID: 12228755
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet?
Guida M; Colucci G
Ann Oncol; 2007 Jun; 18 Suppl 6():vi149-52. PubMed ID: 17591810
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy and targeted therapies in metastatic renal cell carcinoma: is there a preferred sequence?
Giuliani J; Drudi F
Cancer Biother Radiopharm; 2012 Oct; 27(8):513-8. PubMed ID: 22738404
[TBL] [Abstract][Full Text] [Related]
20. Novel immunotherapy in metastatic renal cell carcinoma.
Cho YH; Kim MS; Chung HS; Hwang EC
Investig Clin Urol; 2017 Jul; 58(4):220-227. PubMed ID: 28681030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]